BELLUS Health Inc. (BLU) Social Stream
BELLUS HEALTH INC (BLU) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BLU.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 8 | $16 | $7.5 | $10.916 | $14.74 | -25.94% |
| 2021-12-07 | 7 | $16 | $7.5 | $11.25 | $14.74 | -23.68% |
| 2021-12-14 | 8 | $20 | $7.5 | $13.687 | $14.74 | -7.14% |
| 2022-01-24 | 8 | $20 | $7.5 | $13.562 | $14.74 | -7.99% |
| 2022-02-02 | 8 | $20 | $9 | $14.625 | $14.74 | -0.78% |
| 2022-05-13 | 8 | $20 | $9 | $14.875 | $14.74 | 0.92% |
| 2022-07-13 | 8 | $20 | $14 | $17.142 | $14.74 | 16.3% |
| 2022-08-24 | 7 | $20 | $14 | $17.571 | $14.74 | 19.21% |
| 2022-09-23 | 7 | $21 | $15 | $18.571 | $14.74 | 25.99% |
| 2022-10-03 | 7 | $21 | $15 | $18.857 | $14.74 | 27.93% |
| 2022-11-16 | 8 | $21 | $15 | $19 | $14.74 | 28.9% |
| 2023-04-05 | 8 | $24 | $15 | $19.375 | $14.74 | 31.45% |
| 2023-04-06 | 8 | $24 | $15 | $19.625 | $14.74 | 33.14% |
| 2023-04-18 | 8 | $24 | $14.75 | $19.218 | $14.74 | 30.38% |
| 2023-04-19 | 8 | $20 | $14.75 | $16.531 | $14.74 | 12.15% |
| 2023-05-18 | 7 | $20 | $14.75 | $16.714 | $14.74 | 13.39% |
The Trend in the Analyst Price Target
Over the past 12 months, BLU's average price target has gone up $1.84.
Over the past 44 weeks, BLU's average upside potential has been 72.44%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-13 | 7 | 20 | 9.00 | 16.125 | 10.09 | 59.81% |
| 2022-09-23 | 7 | 21 | 15.00 | 18.571 | 10.23 | 81.53% |
| 2023-04-06 | 8 | 24 | 15.00 | 19.625 | 6.80 | 188.6% |
| 2023-05-18 | 7 | 20 | 14.75 | 16.714 | 14.43 | 15.83% |
| 2023-05-18 | 7 | 20 | 14.75 | 16.750 | 14.43 | 16.08% |
BLU Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.14 | 3 | 0 | 4 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
BLU's average broker recommendation rating worsened by 1 over the prior 18 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BLU as an investment opportunity.
- In terms of how BELLUS HEALTH INC fares relative to all US stocks, note that its average analyst price target is greater than 455.34% of that group.
- BLU has a higher number of analysts covering the stock than 2030.92% of stocks in the small market cap category.
- BLU has a higher upside potential (average analyst target price relative to current price) than 334.38% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, BELLUS HEALTH INC's variance in analysts' estimates is lower than -701.92% of them.
In the Pharmaceutical Products industry, CLNN, ONCY, and AQST are the three stocks most similar to BELLUS HEALTH INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for BLU? Use POWR Ratings for clearer insight into price direction.